p-MAPK1 expression associated with poor prognosis in angioimmunoblastic T-cell lymphoma patients.


Peripheral T-cell lymphomas (PTCLs) are a heterogeneous group of non-Hodgkin lymphomas, characterized by their striking clinical and biological heterogeneity and non-specific therapeutic regimens. Recent advances in our understanding of PTCL biology have enabled the identification of novel therapeutic targets that could lead to individualized biomarker… (More)
DOI: 10.1111/bjh.13972


2 Figures and Tables